Alberto A Chiappori

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 07, 2022
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer.

Alberto A Chiappori, Ben Creelan, Tawee Tanvetyanon

Pageof 1

Frequent Collaborators

1 joint publications

Ben Creelan

1 joint publications

Theresa A Boyle

1 joint publications

Erick Morris

1 joint publications

Felipe K Hurtado